Shanghai exchange eases rules for biopharmas listing on new innovation board

Revised rules for a new science and technology board loosen requirements for biopharma and tech companies seeking to list on the Shanghai Stock Exchange.

Implemented March 1, the rules update draft rules released Jan. 29 that included

Read the full 375 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE